Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...

A compelling session at the EHA Congress explored how space research is reshaping our understanding of hematologic processes.

Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension ...

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

Adolescent and young adult (AYA) patients with hematological diseases have unique needs that require a multidisciplinary ...

CHICAGO — Counties in the U.S. with the highest environmental burden, such as increased pollution, had significantly higher ...

For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.

Hematology oncology is a medical specialty concerned with diagnosing and treating blood, bone marrow, and lymphatic system cancers such as leukemia and lymphoma. It is sometimes also referred to as ...

CHICAGO — In this video, Erica L. Mayer, MD, MPH, discusses the SERENA-6 study, which assessed the efficacy of switching to camizestrant plus a CDK 4/6 inhibitor vs. continuing standard ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.